Shenzhen Gebijia Molecular Drug Innovation Center

Shenzhen Gebijia Molecular Drug Innovation Center is a China-based biotechnology company specializing in the discovery and development of next-generation targeted protein degraders. The company leverages its proprietary molecular glue discovery platform to target difficult-to-drug proteins involved in oncology and immunology. By focusing on small molecule induced protein degradation, Gebijia aims to provide novel therapeutic options for patients with solid tumors and hematological malignancies. The center integrates computational design with high-throughput screening to accelerate the development of its internal pipeline, bridging the gap between basic research and clinical application.